Mesoblast Ltd (MESO) is now in the Undervalued zone, suggesting that its current forward PS ratio of 21.25 is considered Undervalued compared with the five-year average of -19.16. The fair price of Mesoblast Ltd (MESO) is between 29.69 to 48.29 according to relative valuation method. Compared to the current price of 14.60 USD , Mesoblast Ltd By Undervalued By 50.83%.

Relative Value

Fair Zone

29.69-48.29

Current Price：14.60

50.83%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Mesoblast Ltd (MESO) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Mesoblast Ltd (MESO) has a current Price-to-Book (P/B) ratio of 38.91. Compared to its 3-year average P/B ratio of 12.60, the current P/B ratio is approximately 208.67% higher. Relative to its 5-year average P/B ratio of 7.86, the current P/B ratio is about 394.72% higher. Mesoblast Ltd (MESO) has a Forward Free Cash Flow (FCF) yield of approximately -2.13%. Compared to its 3-year average FCF yield of -11.12%, the current FCF yield is approximately -80.85% lower. Relative to its 5-year average FCF yield of -12.00%, the current FCF yield is about -82.26% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for MESO competitors is 143.86, providing a benchmark for relative valuation. Mesoblast Ltd Corp (MESO.O) exhibits a P/S ratio of 21.25, which is -85.23% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of MESO increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of MESO in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is MESO currently overvalued or undervalued?

What is Mesoblast Ltd (MESO) fair value?

MESO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Mesoblast Ltd (MESO) is between 29.69 to 48.29 according to relative valuation method.

How does MESO's valuation metrics compare to the industry average?

The average P/S ratio for MESO's competitors is 143.86, providing a benchmark for relative valuation. Mesoblast Ltd Corp (MESO) exhibits a P/S ratio of 21.25, which is -85.23% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Mesoblast Ltd (MESO) as of Mar 02 2026?

As of Mar 02 2026, Mesoblast Ltd (MESO) has a P/B ratio of 38.91. This indicates that the market values MESO at 38.91 times its book value.

What is the current FCF Yield for Mesoblast Ltd (MESO) as of Mar 02 2026?

As of Mar 02 2026, Mesoblast Ltd (MESO) has a FCF Yield of -2.13%. This means that for every dollar of Mesoblast Ltd's market capitalization, the company generates -2.13 cents in free cash flow.

What is the current Forward P/E ratio for Mesoblast Ltd (MESO) as of Mar 02 2026?

As of Mar 02 2026, Mesoblast Ltd (MESO) has a Forward P/E ratio of -194.58. This means the market is willing to pay $-194.58 for every dollar of Mesoblast Ltd's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Mesoblast Ltd (MESO) as of Mar 02 2026?

As of Mar 02 2026, Mesoblast Ltd (MESO) has a Forward P/S ratio of 21.25. This means the market is valuing MESO at $21.25 for every dollar of expected revenue over the next 12 months.

MESO Valuation